The molecular portraits of breast tumors are conserved across microarray platformsZhiyuan Hu, Charles M. Perou, Cheng Fan et al.|BMC Genomics|2006Cited by 1.5k
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast CancerRita Nanda, Laura J. Esserman, Minetta C. Liu et al.|JAMA Oncology|2020Cited by 707
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trialLajos Pusztai, Laura J. Esserman, Christina Yau et al.|Cancer Cell|2021Cited by 330
The impact of site-specific digital histology signatures on deep learning model accuracy and biasFrederick M. Howard, Alexander T. Pearson, James M. Dolezal et al.|Nature Communications|2021Cited by 278
Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast CancerDouglas Yee, Minetta C. Liu, Angela DeMichele et al.|JAMA Oncology|2020Cited by 225